| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |